Clinical Pharmacology & Therapeutics

杂志介绍

Clinical Pharmacology & Therapeutics杂志介绍

《Clinical Pharmacology & Therapeutics》是一本以English为主的未开放获取国际优秀期刊，中文名称临床药理学与治疗学，本刊主要出版、报道医学-PHARMACOLOGY & PHARMACY领域的研究动态以及在该领域取得的各方面的经验和科研成果，介绍该领域有关本专业的最新进展，探讨行业发展的思路和方法，以促进学术信息交流，提高行业发展。该刊已被国际权威数据库SCIE收录，为该领域相关学科的发展起到了良好的推动作用，也得到了本专业人员的广泛认可。该刊最新影响因子为6.3，最新CiteScore 指数为12.7。

本刊近期中国学者发表的论文主要有：

• Assessment of the Delay in Novel Anticancer Drugs between China and the United States: A Comparative Study of Drugs Approved between 2010 and 2021

  Author: Luo, Xingxian; Du, Xin; Li, Zhuangqi; Qian, Feng; Yang, Yue

• Development of Therapeutic Proteins for a New Subcutaneous Route of Administration after the Establishment of Intravenous Dosages: A Systematic Review

  Author: Xu, Zhenhua; Leu, Jocelyn H. H.; Xu, Yan; Nnane, Ivo; Liva, Sophia G. G.; Wang-Lin, Shun Xin; Kudgus-Lokken, Rachel; Vermeulen, An; Ouellet, Daniele

• Physiologically-Based Pharmacokinetic Modeling of Omalizumab to Predict the Pharmacokinetics and Pharmacodynamics in Pediatric Patients

  Author: Guo, Guimu; You, Xiang; Wu, Wanhong; Chen, Jiarui; Ke, Meng; Lin, Rongfang; Huang, Pinfang; Lin, Cuihong

• The Association Between Baseline Hepatic or Renal Function and Clinical Outcomes for Patients With Non-Small Cell Lung Cancer Treated With a PD-1/PD-L1 Blocking Antibody Using Real-World and Trial Data

  Author: Liu, Qi; Mathur, Raina; Xu, Yuan; Torres, Aracelis Z.; Miksad, Rebecca A.; Liu, Chao; Smithson, Haixia; Wang, Yaning; Zhu, Hao; Booth, Brian; Huang, Shiew-Mei; Zhi, Jizu; Sridhara, Rajeshwari; Blumenthal, Gideon Michael; Larkins, Erin; Mishra-Kalyani, Pallavi S.; Rivera, Donna R.; Kluetz, Paul G.; Sharon, Elad

英文介绍

Clinical Pharmacology & Therapeutics杂志英文介绍

Clinical Pharmacology & Therapeutics (CPT) is the authoritative cross-disciplinary journal in experimental and clinical medicine devoted to publishing advances in the nature, action, efficacy, and evaluation of therapeutics. CPT welcomes original Articles in the emerging areas of translational, predictive and personalized medicine; new therapeutic modalities including gene and cell therapies; pharmacogenomics, proteomics and metabolomics; bioinformation and applied systems biology complementing areas of pharmacokinetics and pharmacodynamics, human investigation and clinical trials, pharmacovigilence, pharmacoepidemiology, pharmacometrics, and population pharmacology.